Search results for "Replacement"

showing 10 items of 561 documents

The role of pain and functional impairment in the decision to recommend total joint replacement in hip and knee osteoarthritis: an international cros…

2011

Import JabRef | WosArea Orthopedics; Rheumatology; International audience; Objective: To assess the pain and functional disability levels corresponding to an indication for total joint replacement (TJR) in hip and knee osteoarthritis (OA). Methods: Design: International cross-sectional study in 10 countries. Patients: Consecutive outpatients with definite hip or knee OA attending an orthopaedic outpatient clinic. Gold standard measure for recommendation for TJR: Surgeon's decision that TJR is justified. Outcome measures: Pain (ICOAP: intermittent and constant osteoarthritis pain, 0-100) and functional impairment (HOOS-PS/KOOS-PS: Hip/Knee injury and Osteoarthritis Outcome Score Physical fun…

MaleSURGERYmedicine.medical_treatmentArthroplasty Replacement HipOsteoarthritisSeverity of Illness IndexOsteoarthritis HipRADIOGRAPHIC FEATURESDisability Evaluation0302 clinical medicineMedicineOutpatient clinicOrthopedics and Sports Medicine030212 general & internal medicinePREDICTORSArthroplasty Replacement KneePain Measurement/methodsPain/diagnosisPain Measurementddc:616ASSOCIATIONOsteoarthritis KneeMiddle Aged3. Good healthPRIORITIZATIONTRIALS[ SCCO.NEUR ] Cognitive science/NeuroscienceFemaleOsteoarthritis Hip/physiopathology/surgerymusculoskeletal diseasesmedicine.medical_specialtyJoint replacementSymptomDecision MakingBiomedical EngineeringPainArticle03 medical and health sciencesRheumatologySeverity of illnessOsteoarthritisPHYSICAL-FUNCTIONHumansKneeARTHROPLASTYRheumatology and AutoimmunityAged030203 arthritis & rheumatologyHip surgeryHipOsteoarthritis Knee/physiopathology/surgerybusiness.industry[SCCO.NEUR]Cognitive science/NeuroscienceJoint replacementGold standard[SCCO.NEUR] Cognitive science/NeuroscienceOUTCOME MEASUREKnee Hip Osteoarthritis Joint replacement Surgery Symptom radiographic features physical-function outcome measure arthroplasty severity surgery trials prioritization association predictorsmedicine.diseaseArthroplastySEVERITYCross-Sectional StudiesOrthopedic surgeryPhysical therapySurgerybusiness
researchProduct

Anti-atherogenic Effects of 17β-Estradiol

2013

Estrogens are secreted primarily by the ovaries and placenta, by the testes in men and also produced by peripheral steroidogenic conversion. The 3 major naturally occurring estrogens are: 17β-estradiol (E2), estrone and estriol, of which E2 is the predominant and most active. The actions of E2 are mediated by at least 3 different receptors - the classical ERs (ERα and ERβ) and G-protein coupled receptor 30 (GPR30). E2 signaling in cardiomyocytes involves ERα- and ERβ-independent pathways, and treatment with the E2 receptor antagonists (Selective Estrogen Receptor Modulators- SERMs), which are agonists of GPR30, inhibits cardiac cell growth. Effects of E2 in preventing endothelial dysfunctio…

MaleSelective Estrogen Receptor Modulatorsmedicine.medical_specialtyVascular smooth muscleEndotheliummedicine.drug_classEndocrinology Diabetes and MetabolismOvariectomyClinical BiochemistryInflammation030204 cardiovascular system & hematologyBiologyBiochemistry03 medical and health sciencesestrogen 17β-estradiol atherogenic factors atherosclerosis0302 clinical medicineEndocrinologyRisk FactorsInternal medicinemedicineAnimalsHumansEndothelial dysfunctionReceptorEstradiolBiochemistry (medical)Estrogen Replacement TherapyGeneral Medicinemedicine.diseaseAtherosclerosis3. Good healthmedicine.anatomical_structureEndocrinologySelective estrogen receptor modulatorEstrogen030220 oncology & carcinogenesisDiet AtherogenicFemalemedicine.symptomGPER
researchProduct

Fluid challenges in intensive care: the FENICE study: a global inception cohort study

2015

Background: Fluid challenges (FCs) are one of the most commonly used therapies in critically ill patients and represent the cornerstone of hemodynamic management in intensive care units. There are clear benefits and harms from fluid therapy. Limited data on the indication, type, amount and rate of an FC in critically ill patients exist in the literature. The primary aim was to evaluate how physicians conduct FCs in terms of type, volume, and rate of given fluid; the secondary aim was to evaluate variables used to trigger an FC and to compare the proportion of patients receiving further fluid administration based on the response to the FC. Methods: This was an observational study conducted i…

MaleSoins intensifs réanimationmedicine.medical_treatmentCohort Studies; Female; Humans; Male; Middle Aged; Practice Patterns Physicians'; Critical Care; Fluid Therapy; Critical Care and Intensive Care MedicinePractice PatternsESICM Trial GroupCritical Care and Intensive Care MedicineRESPONSIVENESSCohort StudiesSeven-Day Profile PublicationMedicine and Health SciencesPractice Patterns Physicians'FENICE InvestigatorsCIRCULATORY SHOCKintensive careddc:617RENAL REPLACEMENT THERAPYMiddle Aged3. Good healthOF-THE-LITERATURESHOCKFemalelipids (amino acids peptides and proteins)Erratumintensive care fluid therapyfluidsLife Sciences & BiomedicineCRITICALLY-ILL PATIENTSHumanCohort studymedicine.medical_specialtyCritical CareHYDROXYETHYL STARCH 130/0.4MEDLINE1117 Public Health and Health ServicesNOfluid therapyCritical Care MedicineCIRCULATORYGeneral & Internal MedicineIntensive careAnesthesiologyPATIENTSmedicinecohort studyHumansRenal replacement therapyIntensive care medicineintensive care; fluids; cohort studyPhysicians'Science & TechnologyCRITICALLY-ILLbusiness.industrySeptic shockSEPTIC SHOCK1103 Clinical Sciences3126 Surgery anesthesiology intensive care radiologymedicine.diseaseEmergency & Critical Care MedicineARTERIAL-PRESSURESEVERE SEPSISClinical trialFluid TherapyObservational studyCohort Studiebusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyTASK-FORCE
researchProduct

Quantification of intramuscular fat in patients with late-onset Pompe disease by conventional magnetic resonance imaging for the long-term follow-up …

2018

Objective The objective of this study was to evaluate a quantitative method based on conventional T1-weighted magnetic resonance (MR) imaging to assess fatty muscular degeneration in patients with late-onset Pompe disease and to compare it with semi-quantitative visual evaluation (the Mercuri score). In addition, a long-term retrospective data analysis was performed to evaluate treatment response to enzyme replacement therapy with alglucosidase alfa. Methods MR images of the lumbar spine were acquired in 41 patients diagnosed with late-onset Pompe disease from 2006 through 2015. Two independent readers retrospectively evaluated fatty degeneration of the psoas and paraspinal muscles by apply…

MaleSupine position610 Medizinlcsh:MedicineBiochemistry030218 nuclear medicine & medical imagingDiagnostic RadiologyFatschemistry.chemical_compound0302 clinical medicine610 Medical sciencesMedicine and Health SciencesAge of Onsetlcsh:ScienceChildMusculoskeletal SystemObserver VariationMultidisciplinarymedicine.diagnostic_testbiologyGlycogen Storage Disease Type IIPharmaceuticsOrganic Compounds10042 Clinic for Diagnostic and Interventional RadiologyRadiology and ImagingMusclesEnzyme replacement therapyMuscle AnalysisMiddle AgedMagnetic Resonance ImagingLipidsChemistryBioassays and Physiological AnalysisAdipose TissuePhysical SciencesFemaleIntramuscular fatAnatomymedicine.drugResearch ArticleSpirometryAdultmedicine.medical_specialtyAdolescentImaging TechniquesUrologyMuscle Tissue610 Medicine & health1100 General Agricultural and Biological SciencesCreatineResearch and Analysis Methods03 medical and health sciencesYoung AdultDrug TherapyDiagnostic Medicine1300 General Biochemistry Genetics and Molecular BiologymedicineHumansEnzyme Replacement TherapyMuscle SkeletalAlglucosidase alfaAgedRetrospective Studies1000 Multidisciplinarybusiness.industrylcsh:ROrganic ChemistryChemical CompoundsBiology and Life SciencesMagnetic resonance imagingalpha-GlucosidasesCreatineBiological TissuechemistrySkeletal Musclesbiology.proteinlcsh:QCreatine kinasebusiness030217 neurology & neurosurgeryFollow-Up Studies
researchProduct

Valve prosthesis-patient mismatch: hemodynamic, echocardiographic and clinical consequences

2011

OBJECTIVES: The purpose is to evaluate in vivo at rest and under stress conditions hemodynamic performance of the small size St. Jude Medical Regent (SJMR) prosthetic valve in patients with a body surface area (BSA) of 1.8 ± 0.11 m(2) and to define the role of valve prosthesis- patient mismatch on left ventricular mass regression following aortic valve replacement. METHODS: We evaluated 25 cases (12 males and 13 females, mean age 65.2 ± 8 years) of aortic valve replacement (17 mm SJMR in three cases and 19 mm SJMR in 22 cases). All the patients underwent at rest Doppler echocardiography before and after surgery and both basal and dobutamine stress echocardiography (DSE) at follow-up. The me…

MaleTime FactorsBody Surface Areamedicine.medical_treatmentLeft ventricular maHemodynamicsDoppler echocardiographyVentricular Function LeftValve replacementAortic valve replacementDobutamineCardiac skeletonBody surface areaHeart Valve Prosthesis ImplantationEjection fractionmedicine.diagnostic_testVentricular RemodelingMiddle AgedEchocardiography DopplerTreatment OutcomeAortic ValveHeart Valve ProsthesisCardiologyFemaleHypertrophy Left VentricularCardiology and Cardiovascular MedicineEchocardiography StressPulmonary and Respiratory Medicinemedicine.medical_specialtyProsthesis DesignPreoperative carePredictive Value of TestsInternal medicineProsthesis-patient mismatch; Left ventricular mass; Effective orifice area; DobutaminemedicineHumansAgedRetrospective StudiesChi-Square Distributionbusiness.industryHemodynamicsProsthesis-patient mismatchStroke VolumeSettore MED/23 - Chirurgia CardiacaAortic Valve StenosisRecovery of Functionmedicine.diseaseEffective orifice areaSurgerybusiness
researchProduct

Bone mineral density of the proximal femur after hip resurfacing arthroplasty: 1-year follow-up study

2011

Abstract Background Hip resurfacing arthroplasty (HRA) is considered a bone-preserving procedure and may eliminate proximal femoral stress shielding and osteolysis. However, in addition to implant-related stress-shielding factors, various patient-related factors may also have an effect on bone mineral density (BMD) of the proximal femur in patients with HRA. Thus, we studied the effects of stem-neck angle, demographic variables, and physical functioning on the BMD of the proximal femur in a one-year follow-up. Methods Thirty three patients (9 females and 24 males) with a mean (SD) age of 55 (9) years were included in the study. BMD was measured two days and 3, 6, and 12 months postoperative…

MaleTime Factorslcsh:Diseases of the musculoskeletal systemBone densityArthroplasty Replacement Hipmedicine.medical_treatmentdual energy X-ray absorptiometry02 engineering and technologySeverity of Illness IndexOsteoarthritis HipAbsorptiometry Photon0302 clinical medicineBone DensityOrthopedics and Sports MedicineFemurProspective StudiesFinlandstress shielding2. Zero hungerBone mineral030222 orthopedicsmedicine.diagnostic_teststem-neck angleMiddle AgedStress shieldingHip resurfacingREPLACEMENTTreatment Outcomemedicine.anatomical_structureFemaleResearch Articlebone remodeling dual energy X-ray absorptiometrymusculoskeletal diseasesmedicine.medical_specialtyeducation0206 medical engineering03 medical and health sciencesFemoral headPOSTERIOR APPROACHRheumatologymedicineHumansFemurPRESERVATIONbone remodelingNECKDual-energy X-ray absorptiometrybusiness.industry3126 Surgery anesthesiology intensive care radiology020601 biomedical engineeringArthroplastySurgeryLogistic Models5-YEARMODESABSORPTIOMETRYFEMORAL-HEADlcsh:RC925-935businessNuclear medicineFollow-Up StudiesBMC Musculoskeletal Disorders
researchProduct

Short-term and long-term results of cardiac surgery in elderly and very elderly patients

2011

Objective: Cardiac operations in elderly patients are increasingly frequent and imply major clinical, ethical, and economic issues. Operative and 5-year results of cardiac operations in patients aged 79 years or more are known in limited series, and a debate is ongoing on the appropriateness of selection of patients for surgery. Methods: We retrospectively reviewed our experience in 6802 patients aged 79 years or more who had received a cardiac operation. Surgical candidates were selected according to functional status, crude operative risk, and social context and were managed according to a multimodality protocol. Results: Mean age was 82 years and surgery was nonelective in 1613 cases (23…

MaleTime Factorsmedicine.medical_treatmentKaplan-Meier Estimatelaw.inventionAMIValve replacementlawRetrospective StudieRisk FactorsThoracic aortaCardiac Surgical ProcedureDuke Activity Status IndexAge FactorMyocardial infarctionHospital MortalityCABGAged 80 and overAge FactorsCanadian Cardiovascular Societycardiopulmonary bypaCardiac surgery"Gruppo Villa Maria"Survival RateGVMTreatment OutcomeItalyElective Surgical Procedurescardiovascular systemCardiologyFemaleCardiology and Cardiovascular MedicineHumanPulmonary and Respiratory Medicinemedicine.medical_specialtyLogistic ModelTime Factoracute myocardial infarctionRisk Assessmentcoronary artery bypass graftInternal medicinemedicine.arteryNew York Heart AssociationmedicineCardiopulmonary bypassHumansCardiac Surgical ProceduresSurvival rateAgedProportional Hazards ModelsRetrospective StudiesElective Surgical Procedurebusiness.industryRisk FactorPatient SelectionCPBRetrospective cohort studyCanadian Cardiovascular SocietySettore MED/23 - Chirurgia Cardiacamedicine.diseaseDASICCSSurgeryLogistic ModelsProportional Hazards ModelSurgeryNYHAbusinessThe Journal of Thoracic and Cardiovascular Surgery
researchProduct

Intra-articular hyaluronic acid injections for hip osteoarthritis

2018

Although viscosupplementation has been used in the past few years both for knee and hip osteoarthritis (OA), the number of intra-articular injections and the interval between doses still remains an undetermined subject. The aim of this open retrospective study was to evaluate the clinical and functional outcome in patients with mild-moderate hip OA treated with a course of 1, 2 or 3 Hyaluronic Acid (HA) intra-articular injections. Ninety-six patients were included: 19 patients received only one injection, 24 received two injections, and 44 received three injections. Age, sex, VAS for pain and WOMAC score before each intra-articular injection, number of intra-articular injections, reasons fo…

MaleViscosupplementationviscosupplementaton knee and hip ostoarthritis intrarticular injections hyaluronic acidTreatment OutcomeArthroplasty Replacement HipSettore MED/34 - Medicina Fisica E RiabilitativaHumansPainFemaleHyaluronic AcidOsteoarthritis HipInjections Intra-ArticularRetrospective Studies
researchProduct

Incidence of Kidney Replacement Therapy and Subsequent Outcomes Among Patients With Systemic Lupus Erythematosus: Findings From the ERA Registry.

2022

RATIONALE AND OBJECTIVE: There is a dearth of data characterizing patients requiring kidney replacement therapy (KRT) for kidney failure due to systemic lupus erythematosus (SLE) and their clinical outcomes. The aim of this study was to describe trends in incidence and prevalence of KRT among these patients as well as to compare their outcomes to patients treated with KRT for diseases other than SLE.STUDY DESIGN: Retrospective cohort study based on kidney registry data.SETTING & PARTICIPANTS: Patients recorded in 14 registries of patients receiving kidney replacement therapy that provided data to the European Renal Association (ERA) Registry between 1992 and 2016.PREDICTOR: SLE as cause…

Malekidney diseasemedicine.medical_treatmentMAINTENANCE DIALYSIS030232 urology & nephrologyLupus nephritislupus nephritis (LN)0302 clinical medicineLupus Erythematosus Systemickidney replacement therapy (KRT)RegistriesRenal InsufficiencyKidney transplantationRISKeducation.field_of_studyKidneyregistry studyIncidence (epidemiology)IncidenceSTAGE RENAL-DISEASELupus Nephritis3. Good healthEuropeRenal Replacement Therapymedicine.anatomical_structureNephrologySURVIVALFemalemedicine.medical_specialtyprevalencePopulationkidney transplantationUNITED-STATESsurvival03 medical and health sciencesAFRICAN-AMERICAN PATIENTSInternal medicinemedicineHumansESRDeducationNEPHRITISDialysisRetrospective Studies030203 arthritis & rheumatologyProportional hazards modelbusiness.industryTRANSPLANTATIONMORTALITYRetrospective cohort studymedicine.diseasekidney failureend-stage renal disease (ESRD)3121 General medicine internal medicine and other clinical medicineSystemic lupus erythematosus (SLE)Kidney Failure ChronicprognosisbusinessAmerican journal of kidney diseases : the official journal of the National Kidney Foundation
researchProduct

Treatment of Fabry Disease management with migalastat-outcome from a prospective 24 months observational multicenter study (FAMOUS).

2020

Abstract Aims Fabry disease (FD) is an X-linked lysosomal storage disorder caused by a deficiency of the lysosomal enzyme α-galactosidase A (GLA/AGAL), resulting in the lysosomal accumulation of globotriaosylceramide (Gb3). Patients with amenable GLA mutations can be treated with migalastat, an oral pharmacological chaperone increasing endogenous AGAL activity. In this prospective observational multicentre study, safety as well as cardiovascular, renal, and patient-reported outcomes and disease biomarkers were assessed after 12 and 24 months of migalastat treatment under ‘real-world’ conditions. Methods and results A total of 54 patients (26 females) (33 of these [61.1%] pre-treated with en…

Malemedicine.medical_specialty1-DeoxynojirimycinGlobotriaosylceramideRenal functionDiseaseGastroenterology03 medical and health scienceschemistry.chemical_compoundInternal medicineMigalastatmedicineHumansPharmacology (medical)Prospective Studies030304 developmental biology0303 health sciencesbusiness.industry030305 genetics & heredityDisease ManagementEnzyme replacement therapymedicine.diseaseFabry diseaseMulticenter studychemistryFabry DiseaseObservational studyFemaleCardiology and Cardiovascular MedicinebusinessEuropean heart journal. Cardiovascular pharmacotherapy
researchProduct